Communiqués Viva Biotech Holdings

Actions

1873

KYG9390W1015

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:09 16/07/2024			Varia. 5j.	Varia. 1 janv.
0,52 ^HKD	+4,00 %		+1,96 %	-50,48 %

28/03	Viva Biotech Holdings publie ses résultats pour l'exercice clos le 31 décembre 2023	CI
18/01	Viva Biotech Holdings nomme WANG Stephen Hui au poste d'administrateur non exécutif	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future	28/03	PR
Viva Biotech Announces 2023 Interim Results Solid Growth in Main Business, Significant Rebound in Profitability	30/08/23	AQ
Viva Biotech (1873.HK) Announces 2023 Interim Results: Solid Growth in Main Business, Significant Rebound in Profitability	29/08/23	PR
Latest Updates of 7 Viva's Portfolio Companies	28/07/23	PR
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs	20/07/23	PR
HONOR Partners with AIGC Artist to Share the Vibe of Upcoming HONOR 90	19/06/23	AQ
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million	16/06/23	PR
Viva Biotech Successfully Held The 3rd Annual Partnership Summit	23/06/22	PR
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7%	28/03/22	PR
Joint Fight Against COVID-19, Viva Biotech Contributes to the Production of the Oral COVID-19 Antiviral Medication and Virus Tests	18/03/22	PR
Viva Biotech : Announced 2021 Interim Results	30/08/21	PR
Viva Biotech : PROPOSED RE-ELECTION OF RETIRING DIRECTORS PROPOSED RE-APPOINTMENT OF AUDITOR PROPOSALS FOR GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND AND NOTICE OF ANNUAL GENERAL MEETING	28/04/21	PU
Viva Biotech : CHANGE OF CHIEF FINANCIAL OFFICER	26/04/21	PU
Viva Biotech : Announced 2020 Annual Results	31/03/21	PR
Viva Biotech : SUPPLEMENTAL ANNOUNCEMENT REGARDING THE ANNOUNCEMENT PUBLISHED ON MARCH 16, 2021	19/03/21	PU
Viva Biotech : (Re-published for debt holders information) PROFIT WARNING	17/03/21	PU
Viva Biotech : COMPLETION OF THE ACQUISITION OF THE ENTIRE EQUITY INTEREST IN SYNTHESIS MED CHEM (HONG KONG) LIMITED INVOLVING ISSUE OF CONSIDERATION SHARES UNDER GENERAL MANDATE	05/03/21	PU
Viva Biotech : MAJOR TRANSACTION IN RELATION TO THE ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL IN SYNTHESIS MED CHEM (HONG KONG) LIMITED	25/02/21	PU
Viva Biotech : PROPOSED INCREASE OF AUTHORIZED SHARE CAPITAL	23/09/20	PU
Viva Biotech : DISCLOSEABLE TRANSACTION-ENTRY INTO THE INVESTMENT AGREEMENT WITH HANGZHOU QIANTANG NEW AREA MANAGEMENT COMMITTEE	22/09/20	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Viva Biotech Holdings

Actions

1873

KYG9390W1015

Communiqués

Filtres